In the first year, graft failure is often due to acute rejection or vascular complications [1].
In the published results from the , the TOPVAS study provided vital data on current kidney graft and patient survival rates, eGFR (estimated glomerular filtration rate) trajectories, and rates of rejection, infection, and surgical complications. The study also established a well-characterized biobank of blood and urine samples to support future discoveries of prognostic methods. It included 241 patients receiving non-living kidney transplants across three Austrian centers, with follow-ups for up to 24 months.
Immunosuppression has historically been managed as a "one-size-fits-all" strategy. However, this frequently results in either under-immunosuppression (leading to chronic organ rejection) or over-immunosuppression. Over-medication can expose the patient to severe adverse events, including: Cardiovascular complications Post-transplant lymphoproliferative disease (PTLD)
Current research on Topvas is exploring:
So, how does Topvas actually work its magic? Here's a closer look at the platform's key features and functionalities:
Maya felt a chill. That’s it , she thought. The human thread .
In the first year, graft failure is often due to acute rejection or vascular complications [1].
In the published results from the , the TOPVAS study provided vital data on current kidney graft and patient survival rates, eGFR (estimated glomerular filtration rate) trajectories, and rates of rejection, infection, and surgical complications. The study also established a well-characterized biobank of blood and urine samples to support future discoveries of prognostic methods. It included 241 patients receiving non-living kidney transplants across three Austrian centers, with follow-ups for up to 24 months.
Immunosuppression has historically been managed as a "one-size-fits-all" strategy. However, this frequently results in either under-immunosuppression (leading to chronic organ rejection) or over-immunosuppression. Over-medication can expose the patient to severe adverse events, including: Cardiovascular complications Post-transplant lymphoproliferative disease (PTLD)
Current research on Topvas is exploring:
So, how does Topvas actually work its magic? Here's a closer look at the platform's key features and functionalities:
Maya felt a chill. That’s it , she thought. The human thread .